← Leaderboards
Jessica Yasmine Islam
Univ Of North Carolina Chapel Hill
$3,515,134
Attributed
$4,082,776
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,282,125 · 5
By mechanism
R01$3,842,746 · 2
U54$199,349 · 1
R03$168,500 · 1
F31$71,530 · 1
Top collaborators
- Yi Guo1 shared
- Mattia Prosperi1 shared
- Kenneth Lynn Wright1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Leah L. Zullig$3,519,508
- Kurt M. Ribisl$35,707,733
- Carla J Chibwesha$4,372,568
- Louise Henderson$9,735,205
- Justin N Baker$1,749,303
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureMortalityCessation Of LifeMalignant NeoplasmsPersonsCaringSocialAdultMorbidity - Disease RateInsightMalignant Neoplasm Of LungHealth SystemCohortCancer DiagnosisHiv SeronegativityElectronic Health RecordDiagnosisFloridaAdherenceBehaviorGeneral PopulationGuidelinesAreaComorbidity
Grant awards (6)
Trends and outcomes of lung cancer screening among people with and without HIV in the US$2,991,283
R01 · FY2025 · CA · contact PI
Harnessing big data to understand the confluence of HIV and cancer stigma in the US Southeast$851,463
R01 · FY2025 · CA · contact PI
Cancer screening behaviors among people with and without HIV in All of Us$199,349
U54 · FY2024 · CA
Health-related quality of life and patient reported outcomes among people living with HIV and cancer$168,500
R03 · FY2023 · CA · contact PI
Assessing clinical validity of cervical cancer self-screening methods$36,005
F31 · FY2018 · CA · contact PI
Assessing clinical validity of cervical cancer self-screening methods$35,525
F31 · FY2017 · CA · contact PI